Applied Molecular Transport Inc. - ESG Rating & Company Profile powered by AI
Check the end of this page for potential risks for Applied Molecular Transport Inc. based on industry, location and size. This webpage of Applied Molecular Transport Inc. is prepared by All Street Sevva using cutting edge NLP. Other companies in the scoring peer group for Applied Molecular Transport Inc. are shown.
Applied Molecular Transport Inc. in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.1; made up of an environmental score of 6.4, social score of 6.4 and governance score of 6.7.
7.1
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 315 | Pluristem Therapeutics Inc | 7.2 | High |
| 315 | Regeneron Pharmaceuticals Inc | 7.2 | High |
| 326 | Applied Molecular Transport Inc. | 7.1 | High |
| 326 | BOD Australia Ltd | 7.1 | High |
| 326 | Abionyx Pharma SA | 7.1 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Applied Molecular Transport Inc. have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose current and historical energy intensity?
Sign up for free to unlockDoes Applied Molecular Transport Inc. report the average age of the workforce?
Sign up for free to unlockDoes Applied Molecular Transport Inc. reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose its ethnicity pay gap?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose cybersecurity risks?
Sign up for free to unlockDoes Applied Molecular Transport Inc. offer flexible work?
Sign up for free to unlockDoes Applied Molecular Transport Inc. have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Applied Molecular Transport Inc. conduct supply chain audits?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Applied Molecular Transport Inc. conduct 360 degree staff reviews?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose the individual responsible for D&I?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose water use targets?
Sign up for free to unlockDoes Applied Molecular Transport Inc. have careers partnerships with academic institutions?
Sign up for free to unlockDid Applied Molecular Transport Inc. have a product recall in the last two years?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose incidents of discrimination?
Sign up for free to unlockDoes Applied Molecular Transport Inc. allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Applied Molecular Transport Inc. issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose parental leave metrics?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose the pay ratio of women to men?
Sign up for free to unlockDoes Applied Molecular Transport Inc. support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Applied Molecular Transport Inc. reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Applied Molecular Transport Inc. involved in embryonic stem cell research?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose its waste policy?
Sign up for free to unlockDoes Applied Molecular Transport Inc. report according to TCFD requirements?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose energy use targets?
Sign up for free to unlockDoes Applied Molecular Transport Inc. disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Applied Molecular Transport Inc. have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Applied Molecular Transport Inc.
These potential risks are based on the size, segment and geographies of the company.
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trial for the treatment of ulcerative colitis and related inflammatory indications. It is also involved in developing AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase Ia clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.